scholarly article | Q13442814 |
P2093 | author name string | Robert E Schmidt | |
Richard W Gross | |||
John Turk | |||
Mary Wohltmann | |||
David F Wozniak | |||
Paul T Kotzbauer | |||
David J Mancuso | |||
Ibrahim Malik | |||
Laura Montier | |||
P2860 | cites work | Misfolding diverts CFTR from recycling to degradation: quality control at early endosomes | Q24676764 |
Differential regulation of EGF receptor internalization and degradation by multiubiquitination within the kinase domain | Q28119149 | ||
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis | Q28131672 | ||
Altered neuronal mitochondrial coenzyme A synthesis in neurodegeneration with brain iron accumulation caused by abnormal processing, stability, and catalytic activity of mutant pantothenate kinase 2 | Q28303208 | ||
Genetic and age related models of neurodegeneration in mice: dystrophic axons | Q28507600 | ||
Neuropathology of gracile axonal dystrophy (GAD) mouse. An animal model of central distal axonopathy in primary sensory neurons | Q28594561 | ||
Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice | Q30764264 | ||
Highly selective hydrolysis of fatty acyl-CoAs by calcium-independent phospholipase A2beta. Enzyme autoacylation and acyl-CoA-mediated reversal of calmodulin inhibition of phospholipase A2 activity | Q33238930 | ||
Widespread expression of alpha-synuclein and tau immunoreactivity in Hallervorden-Spatz syndrome with protracted clinical course | Q34019790 | ||
PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron | Q34568479 | ||
Neuropathology and pathogenesis of diabetic autonomic neuropathy | Q34800404 | ||
PLA2G6 mutation underlies infantile neuroaxonal dystrophy | Q35221441 | ||
Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gamma-synuclein neuropathology | Q35745646 | ||
Neuroaxonal dystrophy in aging human sympathetic ganglia | Q35811753 | ||
Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs | Q35906130 | ||
Insulin secretory responses and phospholipid composition of pancreatic islets from mice that do not express Group VIA phospholipase A2 and effects of metabolic stress on glucose homeostasis. | Q36097167 | ||
Spontaneous murine neuroaxonal dystrophy: a model of infantile neuroaxonal dystrophy | Q36177182 | ||
Male mice that do not express group VIA phospholipase A2 produce spermatozoa with impaired motility and have greatly reduced fertility. | Q37070443 | ||
Lysosomal targeting of E-cadherin: a unique mechanism for the down-regulation of cell-cell adhesion during epithelial to mesenchymal transitions | Q40480362 | ||
Amyloid beta precursor protein and ubiquitin epitopes in human and experimental dystrophic axons. Ultrastructural localization | Q42050045 | ||
Widespread occurrence of alpha-synuclein/NACP-immunoreactive neuronal inclusions in juvenile and adult-onset Hallervorden-Spatz disease with Lewy bodies | Q42479971 | ||
Juvenile-onset generalized neuroaxonal dystrophy (Hallervorden-Spatz disease) with diffuse neurofibrillary and lewy body pathology | Q42483324 | ||
Infantile neuroaxonal dystrophy (Seitelberger's disease). A light and ultrastructural study | Q43572126 | ||
Terminal axon pathology in infantile neuroaxonal dystrophy | Q44734791 | ||
Apoptotic neurodegeneration induced by ethanol in neonatal mice is associated with profound learning/memory deficits in juveniles followed by progressive functional recovery in adults | Q45168372 | ||
Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation | Q47602087 | ||
An analysis of the ultrastructural findings in infantile neuroaxonal dystrophy (Seitelberger's disease). | Q47852922 | ||
Infantile neuroaxonal dystrophy: clinical spectrum and diagnostic criteria | Q48221200 | ||
Diagnostic difficulties in infantile neuroaxonal dystrophy. A clinicopathological study of eight cases | Q48221796 | ||
Histological and ultrastructural features of dystrophic isocortical axons in infantile neuroaxonal dystrophy (Seitelberger's disease). | Q48550671 | ||
Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein | Q48581887 | ||
Infantile neuroaxonal dystrophy. Histological and electron microscopical study of two cases | Q48599352 | ||
Cerebellar synaptic defects and abnormal motor behavior in mice lacking alpha- and beta-dystrobrevin. | Q48616988 | ||
Neuroaxonal dystrophy in young adults: a clinicopathological study of two unrelated cases | Q48957543 | ||
Alpha-synuclein accumulation in a case of neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome) with widespread cortical and brainstem-type Lewy bodies | Q57188685 | ||
Alpha-synuclein immunoreactivity is present in axonal swellings in neuroaxonal dystrophy and acute traumatic brain injury | Q64816474 | ||
Infantile neuroaxonal dystrophy | Q66971406 | ||
Infantile neuroaxonal dystrophy. Early form with preferential cerebellar involvement | Q72183166 | ||
Involvement of group VI Ca2+-independent phospholipase A2 in protein kinase C-dependent arachidonic acid liberation in zymosan-stimulated macrophage-like P388D1 cells | Q77955228 | ||
Both proteasomes and lysosomes degrade the activated erythropoietin receptor | Q80546895 | ||
A new mouse model for infantile neuroaxonal dystrophy, inad mouse, maps to mouse chromosome 1 | Q81696532 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | protein ubiquitination | Q3547638 |
Infantile neuroaxonal dystrophy | Q6029060 | ||
P304 | page(s) | 406-416 | |
P577 | publication date | 2008-01-17 | |
P1433 | published in | The American Journal of Pathology | Q4744259 |
P1476 | title | Disrupted membrane homeostasis and accumulation of ubiquitinated proteins in a mouse model of infantile neuroaxonal dystrophy caused by PLA2G6 mutations | |
P478 | volume | 172 |